Literature DB >> 12649722

Laboratory detection and investigation of reduced susceptibility to vancomycin in oxacillin-resistant Staphylococcus aureus.

P D Midolo1, T M Korman, D Kotsanas, P Russo, T G Kerr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649722     DOI: 10.1007/s10096-003-0895-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

1.  One-point population analysis and effect of osmolarity on detection of hetero-vancomycin-resistant Staphylococcus aureus.

Authors:  Sook-In Jung; Sungmin Kiem; Nam Yong Lee; Yeon-Sook Kim; Won Sup Oh; Hwang Lae Cho; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.

Authors:  Matthew B Avison; Peter M Bennett; Robin A Howe; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

3.  Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin.

Authors:  P B Ward; P D Johnson; E A Grabsch; B C Mayall; M L Grayson
Journal:  Med J Aust       Date:  2001-11-05       Impact factor: 7.738

4.  Low-level resistance to glycopeptides amongst staphylococcus species: surveillance in a university hospital and evaluation of a vancomycin screening agar.

Authors:  Y J Park; J Jun Park; S O Lee; E J Oh; B Kee Kim
Journal:  Diagn Microbiol Infect Dis       Date:  2001-11       Impact factor: 2.803

5.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

6.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

7.  First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

Authors:  S Trakulsomboon; S Danchaivijitr; Y Rongrungruang; C Dhiraputra; W Susaemgrat; T Ito; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

8.  Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.

Authors:  R A Howe; M Wootton; P M Bennett; A P MacGowan; T R Walsh
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

9.  A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Authors:  M Wootton; R A Howe; R Hillman; T R Walsh; P M Bennett; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

10.  Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.

Authors:  T R Walsh; A Bolmström; A Qwärnström; P Ho; M Wootton; R A Howe; A P MacGowan; D Diekema
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

View more
  2 in total

1.  In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.

Authors:  N McCallum; H Karauzum; R Getzmann; M Bischoff; P Majcherczyk; B Berger-Bächi; R Landmann
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 2.  Molecular diagnostics of clinically important staphylococci.

Authors:  J Stepán; R Pantůcek; J Doskar
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.